Unlocking Longevity with Low Dose Naltrexone (LDN)

Low Dose Naltrexone (LDN) has emerged as a promising tool in the pursuit of healthy aging and longevity. Originally approved for treating opioid and alcohol dependency, LDN has gained attention in recent years for its off-label use in supporting immune function, reducing inflammation, and promoting overall health. Researchers and practitioners alike are exploring how LDN can contribute to extending lifespan and enhancing quality of life.

What is Low Dose Naltrexone (LDN)?

Naltrexone, in its standard dosage, is a medication that blocks opioid receptors in the brain. In significantly lower doses (typically 0.5 to 4.5 mg), it has been shown to have a completely different mechanism of action. LDN is thought to temporarily block opioid receptors, prompting a rebound increase in endorphins and enkephalins—naturally occurring chemicals that regulate pain, mood, and the immune system. This unique property makes it a compelling option for addressing age-related conditions.